Imperial College London

Dr Francine Heatley

Faculty of MedicineDepartment of Surgery & Cancer

Clinical Trials Manager
 
 
 
//

Contact

 

+44 (0)20 3311 7371f.heatley Website

 
 
//

Location

 

3E4East WingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Grieve:2015:eurheartj/ehv125,
author = {Grieve, R and Gomes, M and Sweeting, MJ and Ulug, P and Hinchliffe, RJ and Thompson, MM and Thompson, SG and Ashleigh, R and Greenhalgh, RM and Powell, JT and IMPROVE, trial investigators},
doi = {eurheartj/ehv125},
journal = {European Heart Journal},
pages = {2061--2069},
title = {Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: one-year outcomes from the IMPROVE randomized trial},
url = {http://dx.doi.org/10.1093/eurheartj/ehv125},
volume = {36},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - AIMS: To report the longer term outcomes following either a strategy of endovascular repair first or open repair of ruptured abdominal aortic aneurysm, which are necessary for both patient and clinical decision-making. METHODS AND RESULTS: This pragmatic multicentre (29 UK and 1 Canada) trial randomized 613 patients with a clinical diagnosis of ruptured aneurysm; 316 to an endovascular first strategy (if aortic morphology is suitable, open repair if not) and 297 to open repair. The principal 1-year outcome was mortality; secondary outcomes were re-interventions, hospital discharge, health-related quality-of-life (QoL) (EQ-5D), costs, Quality-Adjusted-Life-Years (QALYs), and cost-effectiveness [incremental net benefit (INB)]. At 1 year, all-cause mortality was 41.1% for the endovascular strategy group and 45.1% for the open repair group, odds ratio 0.85 [95% confidence interval (CI) 0.62, 1.17], P = 0.325, with similar re-intervention rates in each group. The endovascular strategy group and open repair groups had average total hospital stays of 17 and 26 days, respectively, P < 0.001. Patients surviving rupture had higher average EQ-5D utility scores in the endovascular strategy vs. open repair groups, mean differences 0.087 (95% CI 0.017, 0.158), 0.068 (95% CI -0.004, 0.140) at 3 and 12 months, respectively. There were indications that QALYs were higher and costs lower for the endovascular first strategy, combining to give an INB of £3877 (95% CI £253, £7408) or €4356 (95% CI €284, €8323). CONCLUSION: An endovascular first strategy for management of ruptured aneurysms does not offer a survival benefit over 1 year but offers patients faster discharge with better QoL and is cost-effective. CLINICAL TRIAL REGISTRATION: ISRCTN 48334791.
AU - Grieve,R
AU - Gomes,M
AU - Sweeting,MJ
AU - Ulug,P
AU - Hinchliffe,RJ
AU - Thompson,MM
AU - Thompson,SG
AU - Ashleigh,R
AU - Greenhalgh,RM
AU - Powell,JT
AU - IMPROVE,trial investigators
DO - eurheartj/ehv125
EP - 2069
PY - 2015///
SN - 1522-9645
SP - 2061
TI - Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: one-year outcomes from the IMPROVE randomized trial
T2 - European Heart Journal
UR - http://dx.doi.org/10.1093/eurheartj/ehv125
UR - https://academic.oup.com/eurheartj/article/36/31/2061/2398075
UR - http://hdl.handle.net/10044/1/24614
VL - 36
ER -